Lernziele
Der Leser soll nach dem Durcharbeiten des Artikels
-
die Indikation hinsichtlich des Mindestknochenangebots vor Implantation stellen können,
-
die Relevanz der biologischen Knochenheilungsvorgänge für den klinischen Erfolg von Augmentationen sowie die Phasen der Knochenheilung verstehen,
-
die Vorteile und Limitationen des autologen Augmentats kennen,
-
über die aktuell klinisch verfügbaren Modalitäten synthetischer Knochenersatzmaterialien Bescheid wissen und
-
die Möglichkeiten und insbesondere die Limitierung der Verwendung synthetischer Knochenersatzmaterialien überblicken.
Literatur
-
1
Aghaloo TL, Moy PK..
Which hard tissue augmentation techniques are the most successfull in furnishing bony support for implant placement?.
Int J Oral Maxillofac Implants.
2007;
22
49-70
-
2
Bhatnagar RS, Qian JJ, Wedrychowska A. et al. .
Design of biomimetic habitats for tissue engineering with P–15, a synthetic peptide analogue of collagen.
Tissue Eng.
1999;
5
53-65
-
3
Brugnami F, Then PR, Moroi H. et al. .
Histologic evaluation of human extraction sockets treated with demineralized freeze–dried bone allograft (DFDBA) and cell occlusive membrane.
J Periodontol.
1996;
67
821-825
-
4
Buck BE, Resnick L, Shah SM. et al. .
Human immunodeficiency virus cultured from bone. Implications for transplantation.
Clin Orthop Relat Res.
1990;
251
249-253
-
5
Cammack 2nd GV, Nevins M, Clem 3rd DS. et al. .
Histologic evaluation of mineralized and demineralized freeze–dried bone allograft for ridge and sinus augmentations.
Int J Periodontics Restorative Dent.
2005;
25
231-237
-
6
Chung EM, Sung EC..
Dental management of chemoradiation patients.
J Calif Dent Assoc.
2006;
34
735-742
-
7
Cricchio G, Lundgren S..
Donor site morbidity in two different approaches to anterior iliac crest bone harvesting.
Clin Implant Dent Relat Res.
2003;
5
161-169
-
8
Kim SS, Park MS, Gwak SJ. et al. .
Accelerated bonelike apatite growth on porous polymer/ceramic composite scaffolds in vitro.
Tissue Eng.
2006;
12
2997-3006
-
9
Klongnoi B, Rupprecht S, Kessler P. et al. .
Influence of platelet–rich plasma on a bioglass and autogenous bone in sinus augmentation. An explorative study.
Clin Oral Implants Res.
2006;
17
312-320
-
10
Nkenke E, Radespiel–Troger M, Wiltfang J. et al. .
Morbidity of harvesting of retromolar bone grafts: a prospective study 31.
Clin Oral Implants Res.
2002;
3
514-521
-
11
Oka K, Oka S, Sasaki T. et al. .
The role of TGF–beta signaling in regulating chondrogenesis and osteogenesis during mandibular development.
Dev Biol.
2007;
303
391-404
-
12
Precheur HV..
Bone Graft Materials.
Dent Clin North Am.
2007;
51
729-746
-
13
Schindeler A, McDonald MM, Bokko P. et al. .
Bone remodeling during fracture repair: The cellular picture.
Semin Cell Dev Biol.
2008;
19
459-466
-
14
Schlegel AK, Donath K..
BIO–OSS––a resorbable bone substitute?.
J Long Term Eff Med Implants.
1998;
8
201-209
-
15
Schlegel KA, Fichtner G, Schultze–Mosgau S. et al. .
Histologic findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute.
Int J Oral Maxillofac Implants.
2003;
18
53-58
-
16
Schlegel KA, Kloss FR, Kessler P. et al. .
Bone conditioning to enhance implant osseointegration: an experimental study in pigs.
Int J Oral Maxillofac Implants.
2003;
18
505-511
-
17
Schlegel KA, Kloss FR, Schultze–Mosgau S. et al. .
(Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation).
Mund Kiefer Gesichtschir.
2003;
7
112-118
-
18
Schlegel KA, Schultze–Mosgau S, Wiltfang J. et al. .
Changes of mineralization of free autogenous bone grafts used for sinus floor elevation.
Clin Oral Implants Res.
2006;
17
673-678
-
19
Schlegel KA, Thorwarth M, Plesinac A. et al. .
Expression of bone matrix proteins during the osseus healing of topical conditioned implants: an experimental study.
Clin Oral Implants Res.
2006;
17
666-672
-
20 Schlegel KA, Zimmermann R, Thorwarth M. et al. .Sinus floor elevation using autogenous bone or bone substitute combined with platelet–rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007
-
21
Springer IN, Nocini PF, Schlegel KA. et al. .
Two techniques for the preparation of cell–scaffold constructs suitable for sinus augmentation: steps into clinical application.
Tissue Eng.
2006;
12
2649-2656
-
22
Thorwarth M, Schultze–Mosgau S, Wehrhan F. et al. .
Enhanced bone regeneration with a synthetic cell–binding peptide––in vivo results.
Biochem Biophys Res Commun.
2005;
329
789-795
-
23
Urist MR, Huo YK, Brownell AG. et al. .
Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography.
Proc Natl Acad Sci USA.
1984;
81
371-375
-
24
Valimaki VV, Aro HT..
Molecular basis for action of bioactive glasses as bone graft substitute.
Scand J Surg.
2006;
95
95-102
-
25
Warnke PH, Wiltfang J, Springer I. et al. .
Man as living bioreactor: fate of an exogenously prepared customized tissue–engineered mandible.
Biomaterials.
2006;
27
3163-3167
-
26
Wehrhan F, Grabenbauer GG, Rodel F. et al. .
Exogenous modulation of TGF–beta(1) influences TGF–betaR–III–associated vascularization during wound healing in irradiated tissue.
Strahlenther Onkol.
2004;
180
526-533
-
27
Wiltfang J, Merten HA, Schlegel KA. et al. .
Degradation characteristics of alpha and beta tri–calcium–phosphate (TCP) in minipigs 36.
J Biomed Mater Res.
2002;
63
115-121
-
28
Wiltfang J, Merten HA, Schlegel KA. et al. .
Degradation characteristics of alpha and beta tri–calcium–phosphate (TCP) in minipigs.
J Biomed Mater Res.
2002;
63
115-121
-
29
Wiltfang J, Schlegel KA, Schultze–Mosgau S. et al. .
Sinus floor augmentation with beta–tricalciumphosphate (beta–TCP): does platelet–rich plasma promote its osseous integration and degradation?.
Clin Oral Implants Res.
2003;
14
213-218
-
30
Wiltfang J, Schultze–Mosgau S, Nkenke E. et al. .
Onlay augmentation versus sinuslift procedure in the treatment of the severely resorbed maxilla: a 5–year comparative longitudinal study.
Int J Oral Maxillofac Surg.
2005;
34
885-889
Korrespondenzadresse
Dr. Falk Wehrhan
Mund–, Kiefer– und Gesichtschirurgische Klinik Universitätsklinikum Erlangen
Glückstrasse 11
91054 Erlangen
eMail: Falk.Wehrhan@uk-erlangen.de
